Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Optimizing pharmacotherapy for bipolar alcoholics

Trial Profile

Optimizing pharmacotherapy for bipolar alcoholics

Phase of Trial: Phase I/II

Latest Information Update: 05 Oct 2016

At a glance

  • Drugs Naltrexone (Primary) ; Valproate semisodium (Primary)
  • Indications Alcoholism; Bipolar disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Feb 2013 Planned end date changed from 1 May 2012 to 1 Nov 2013 as reported by ClinicalTrials.gov.
    • 19 Feb 2009 Additional trial centre added as reported by ClinicalTrials.gov, last updated 19 Feb 2009.
    • 19 Feb 2009 Trial phase changed from II to I/II as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top